Expression and prognostic significance of serum response factor in cholangiocarcinoma

Korean Journal of Pathology

Volumn 43, Issue 6, 2009, Pages 517-522

  Park, Shin Young ^a   Jang, Kyu Yun ^a   Kim, Yo Na ^a   Kim, Hee Jin ^a   Park, Ho Sung ^a   Chung, Myoung Ja ^a   Yu, Hee Chul ^a   Cho, Baik Hwan ^a   Kim, Kyoung Ryul ^b   Moon, Woo Sung ^a  

^a Chonbuk National University   (South Korea)

^b National Institute of Scientific Investigation   (South Korea)

Author keywords

Cholangiocarcinoma; Liver; Serum response factor

Indexed keywords

EID: 77951229724     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2009.43.6.517     Document Type: Article

References (27)

1. Esposito I, Schirmacher P. Pathological aspects of cholangiocarcinoma. HPB 2008; 10: 83-6.
2. Shore P, Sharrocks AD. The MADS-box family of transcription factors. Eur J Biochem 1995; 229: 1-13.
3. Treisman R. Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′element and c-fos 3′sequences. Cell 1985; 42: 889-902.
4. Gilman MZ, Wilson RN, Weinberg RA. Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression. Mol Cell Biol 1986; 6: 4305-16.
5. Treisman R. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 1986; 46: 567-74.
6. Norman C, Runswick M, Pollock R, Treisman R. Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell 1988; 55: 989-1003.
7. Chai J, Tarnawski AS. Serum response factor: discovery, biochemistry, biological roles and implications for tissue injury healing. J Physiol Pharmacol 2002; 53: 147-57.
8. Schratt G, Weinhold B, Lundberg AS, et al. Serum response factor is required for immediate-early gene activation yet is dispensable for proliferation of embryonic stem cells. Mol Cell Biol 2001; 21: 2933-43.
9. Camoretti-Mercado B, Liu HW, Halayko AJ, et al. Physiological control of smooth muscle-specific gene expression through regulated nuclear translocation of serum response factor. J Biol Chem 2000; 275: 30387-93.
10. Ding W, Gao S, Scott RE. Senescence represses the nuclear localization of the serum response factor and differentiation regulates its nuclear localization with lineage specificity. J Cell Sci 2001; 114: 1011-8.
11. Bertolotto C, Ricci JE, Luciano F, Mari B, Chambard JC, Auberger P. Cleavage of the serum response factor during death receptor-induced apoptosis results in an inhibition of the c-FOS promoter transcriptional activity. J Biol Chem 2000; 275: 12941-7.
12. Zhang X, Chai J, Azhar G, et al. Early postnatal cardiac changes and premature death in transgenic mice overexpressing a mutant form of serum response factor. J Biol Chem 2001; 276: 40033-40.
13. Alberti S, Krause SM, Kretz O, et al. Neuronal migration in the murine rostral migratory stream requires serum response factor. Proc Natl Acad Sci USA 2005; 102: 6148-53.
14. Charvet C, Houbron C, Parlakian A, et al. New role for serum response factor in postnatal skeletal muscle growth and regeneration via the interleukin 4 and insulin-like growth factor 1 pathways. Mol Cell Biol 2006; 26: 6664-74.
15. Patten LC, Belaguli NS, Baek MJ, Fagan SP, Awad SS, Berger DH. Serum response factor is alternatively spliced in human colon cancer. J Surg Res 2004; 121: 92-100.
16. Park MY, Kim KR, Park HS, et al. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition. Int J Oncol 2007; 31: 1309-15.
17. Choi HN, Kim KR, Lee JH, et al. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex. Oncol Rep 2009; 21: 57-63.
18. Song XC, Fu G, Yang X, Jiang Z, Wang Y, Zhou GW. Protein expression profiling of breast cancer cells by dissociable antibody microarray (DAMA) staining. Mol Cell Proteomics 2008; 7: 163-9.
19. Gavert N, Ben-Ze@ev A. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med 2008; 14: 199-209.
20. Mejlvang J, Kriajevska M, Berditchevski F, et al. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition. Exp Cell Res 2007; 313: 380-93.
21. Chai J, Jones MK, Tarnawski AS. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis. FASEB J 2004; 18: 1264-6.
22. Lee HJ, Yun CH, Lim SH, et al. SRF is a nuclear repressor of Smad3-mediated TGF-beta signaling. Oncogene 2007; 26: 173-85.
23. Schratt G, Philippar U, Hockemeyer D, Schwarz H, Alberti S, Nordheim A. SRF regulates Bcl-2 expression and promotes cell survival during murine embryonic development. EMBO J 2004; 23: 1834-44.
24. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-5.
25. Sun K, Battle MA, Misra RP, Duncan SA. Hepatocyte expression of serum response factor is essential for liver function, hepatocyte proliferation and survival, and postnatal body growth in mice. Hepatology 2009; 49: 1645-54.
26. Zhang X, Azhar G, Chai J, et al. Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am J Physiol Heart Circ Physiol 2001; 280: H1782-92.
27. Heemers HV, Regan KM, Dehm SM, Tindall DJ. Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer. Cancer Res 2007; 67: 10592-9.